Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

FlexView Diagnostic (v1.1.20)

K-Number: K233226 · 2024-01-17

ApplicantRadical Imaging, LLC
Decision Date2024-01-17
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

FlexView Diagnostic (v1.1.20) is a medical device manufactured by Radical Imaging, LLC. It received FDA 510(k) clearance on 2024-01-17 under approval number K233226. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the FlexView Diagnostic (v1.1.20)?

FlexView Diagnostic (v1.1.20) is a medical device that received FDA 510(k) clearance on 2024-01-17. It is manufactured by Radical Imaging, LLC. The 510(k) number is K233226.

When was FlexView Diagnostic (v1.1.20) approved by the FDA?

FlexView Diagnostic (v1.1.20) received FDA 510(k) clearance on 2024-01-17, under approval number K233226.

What company makes FlexView Diagnostic (v1.1.20)?

FlexView Diagnostic (v1.1.20) is manufactured by Radical Imaging, LLC.

What is the FDA product code for FlexView Diagnostic (v1.1.20)?

The FDA product code for FlexView Diagnostic (v1.1.20) is LLZ.

Related Devices (Code: LLZ)

K161959ClearView cCADClearview Diagnostics, Inc. K163539Ez3D-i / E3Ewoosoft Co., Ltd. K162955Multi-Modality Tumor Tracking (MMTT) applicationPhilips Medical Systems Nederland B.V. K160852ZiaZetta Medical Technologies, LLC K162376CAAS MR 4D FlowPie Medical Imaging BV K161322CT CoPilotZepmed, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑